SecBot SecBot
SECBOTREPLAY Home › Report › EVAX

EVAX · Evaxion receives the 2026 Prix Galien UK Award for Best digital health…

Evaxion · PRESS-RELEASE filed Jun 12, 2026 at 03:00 ET

At the news

NEUTRALIMPACT 3/10

PRESS-RELEASE filed Jun 12, 2026 at 03:00 ET

Evaxion receives the 2026 Prix Galien UK Award for Best digital health solution for its AI-Immunology platform. While this is the second Galien recognition in under a year, it is a non-financial, reputational award that does not change the company's clinical or financial trajectory. The filing contains no revenue, EPS, guidance, or other material financial data.

  • Evaxion awarded the 2026 Prix Galien UK Award for Best digital health solution for AI-Immunology.
  • This is the second recognition from the Prix Galien Foundation in less than a year (previous award in Dec 2025).
  • Evaxion is a clinical-stage TechBio company with no revenue or financial data disclosed in this release.
  • The award committee comprised 12 experts who evaluated innovation, clinical application, and utility.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access